D
Pfizer Inc. PFE
NYSE
Recommendation
Prev Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
52-Week Range
P/E (TTM)
EPS (TTM)

12/31/2023 10/01/2023 07/02/2023 04/02/2023 12/31/2022
Revenue -41.34% -41.55% -54.10% -28.76% 1.90%
Total Other Revenue -- -- -- -- --
Total Revenue -41.34% -41.55% -54.10% -28.76% 1.90%
Cost of Revenue 26.40% -45.25% -64.13% -52.33% 6.84%
Gross Profit -91.84% -40.20% -49.91% -13.81% -1.50%
SG&A Expenses 6.77% 6.03% 4.32% 47.70% 29.38%
Depreciation & Amortization 12.02% 43.43% 44.04% 32.10% 18.18%
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 12.62% -17.71% -32.85% -24.11% 11.00%
Operating Income -233.94% -70.89% -79.14% -35.63% -21.19%
Income Before Tax -178.95% -137.24% -80.18% -30.73% 36.70%
Income Tax Expenses -445.65% -370.79% -104.52% -38.99% -7.63%
Earnings from Continuing Operations -166.68% -127.63% -76.31% -29.50% 39.78%
Earnings from Discontinued Operations -1,400.00% 157.14% -105.88% 111.11% 101.08%
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -12.50% 60.00% -83.33% -116.67% -500.00%
Net Income -167.46% -127.67% -76.51% -29.51% 47.19%
EBIT -233.94% -70.89% -79.14% -35.63% -21.19%
EBITDA -179.96% -60.18% -69.62% -29.46% -15.47%
EPS Basic -167.08% -127.48% -76.73% -29.73% 47.20%
Normalized Basic EPS -211.54% -69.98% -76.28% -31.54% -19.83%
EPS Diluted -169.03% -128.01% -76.41% -29.10% 47.10%
Normalized Diluted EPS -214.08% -69.39% -76.06% -30.95% -19.50%
Average Basic Shares Outstanding 0.57% 0.70% 0.95% 0.30% -0.02%
Average Diluted Shares Outstanding -1.67% -1.26% 0.02% -0.54% -0.43%
Dividend Per Share 2.50% 2.50% 2.50% 2.50% 2.56%
Payout Ratio -2.53% -- 3.39% 0.45% -0.30%
Weiss Ratings